BR0102185A - Use of product comprising catuama extract as an antioxidant or cerebral vasodilating agent, pharmaceutical composition comprising such product for the prophylaxis or treatment of vascular disorders and disorders caused by the improper presence of free radicals, method for the prophylaxis or treatment of cerebral vascular disorders and disorders caused by improper pressing of free radicals using said product and use of said product for the production of a pharmaceutical composition, for the prophylaxis or treatment of vascular disorders and disorders caused by the improper presence of free radicals - Google Patents

Use of product comprising catuama extract as an antioxidant or cerebral vasodilating agent, pharmaceutical composition comprising such product for the prophylaxis or treatment of vascular disorders and disorders caused by the improper presence of free radicals, method for the prophylaxis or treatment of cerebral vascular disorders and disorders caused by improper pressing of free radicals using said product and use of said product for the production of a pharmaceutical composition, for the prophylaxis or treatment of vascular disorders and disorders caused by the improper presence of free radicals

Info

Publication number
BR0102185A
BR0102185A BR0102185-0A BR0102185A BR0102185A BR 0102185 A BR0102185 A BR 0102185A BR 0102185 A BR0102185 A BR 0102185A BR 0102185 A BR0102185 A BR 0102185A
Authority
BR
Brazil
Prior art keywords
product
treatment
prophylaxis
free radicals
disorders
Prior art date
Application number
BR0102185-0A
Other languages
Portuguese (pt)
Inventor
Osvaldo Silva Jr
Tadafissa Fujii
Joao Batista Calixto
Daniela De Almeida Cabrini
Alessandra Beirith
Eunice Andre
Valfredo Schlemper
Elizabeth Soares Fernandes
Original Assignee
Catarinense S A Lab
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Catarinense S A Lab filed Critical Catarinense S A Lab
Priority to BR0102185-0A priority Critical patent/BR0102185A/en
Priority to PCT/BR2001/000091 priority patent/WO2002096441A1/en
Publication of BR0102185A publication Critical patent/BR0102185A/en

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
    • A61K36/18—Magnoliophyta (angiosperms)
    • A61K36/185—Magnoliopsida (dicotyledons)
    • A61K36/77—Sapindaceae (Soapberry family), e.g. lychee or soapberry
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
    • A61K36/18—Magnoliophyta (angiosperms)
    • A61K36/185—Magnoliopsida (dicotyledons)
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
    • A61K36/18—Magnoliophyta (angiosperms)
    • A61K36/185—Magnoliopsida (dicotyledons)
    • A61K36/58—Meliaceae (Chinaberry or Mahogany family), e.g. Azadirachta (neem)
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
    • A61K36/18—Magnoliophyta (angiosperms)
    • A61K36/88—Liliopsida (monocotyledons)
    • A61K36/906—Zingiberaceae (Ginger family)
    • A61K36/9068—Zingiber, e.g. garden ginger
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P7/00—Drugs for disorders of the blood or the extracellular fluid
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00—Drugs for disorders of the cardiovascular system
    • A61P9/08—Vasodilators for multiple indications

Landscapes

  • Health & Medical Sciences (AREA)
  • Natural Medicines & Medicinal Plants (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Engineering & Computer Science (AREA)
  • Veterinary Medicine (AREA)
  • Chemical & Material Sciences (AREA)
  • Public Health (AREA)
  • General Health & Medical Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Animal Behavior & Ethology (AREA)
  • Medical Informatics (AREA)
  • Epidemiology (AREA)
  • Mycology (AREA)
  • Microbiology (AREA)
  • Botany (AREA)
  • Biotechnology (AREA)
  • Alternative & Traditional Medicine (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • General Chemical & Material Sciences (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Organic Chemistry (AREA)
  • Cardiology (AREA)
  • Heart & Thoracic Surgery (AREA)
  • Diabetes (AREA)
  • Hematology (AREA)
  • Medicines Containing Plant Substances (AREA)

Abstract

"USO DE PRODUTO COMPREENDENDO EXTRATO DE CATUAMA COMO AGENTE ANTIOXIDANTE OU COMO AGENTE VASODILATADOR CEREBRAL, COMPOSIçãO FARMACêUTICA COMPREENDENDO TAL PRODUTO PARA A PROFILAXIA OU TRATAMENTO DAS DISFUNçõES VASCULARES E DISTúRBIOS CAUSADOS PELA PRESENçA IMPRóPRIA DE RADICAIS LIVRES, MéTODO PARA A PROFILAXIA OU TRATAMENTO DAS DISFUNçõES VASCULARES CEREBRAIS E DISTúRBIOS CAUSADOS PELA PRESENçA IMPRóPRIA DE RADICAIS LIVRES USANDO O REFERIDO PRODUTO E USO DO REFERIDO PRODUTO PARA PRODUçãO DE UMA COMPOSIçãO FARMACêUTICA PARA A PROFILAXIA OU TRATAMENTO DAS DISFUNçõES VASCULARES E DISTúRBIOS CAUSADOS PELA PRESENçA IMPRóPRIA DE RADICAIS LIVRES". A invenção trata do Uso de um produto de extratos vegetais compreendendo as espécies Trichilia sp, Paullinia cupana (Sapindaceae), Ptychopetalum olacoides (Olacaceae)e Zingiber officinale Zingiberaceae), caracterizado pelo fato de ser <B>um agente antioxidante e/ou agente vasodilatador cerebral<D>. Um produto particularmente Abrangido pelo escopo da invenção é o extrato de Catuama comercialmente disponível como Catuama<32>."UNDERSTANDING PRODUCT USE Catuama EXTRACT AS AGENT ANTIOXIDANTE OR AS AGENT vasodilator BRAIN, PHARMACEUTICAL COMPOSITION COMPRISING SUCH PRODUCT FOR PROPHYLAXIS OR TREATMENT OF DYSFUNCTION VASCULAR AND DISORDERS CAUSED BY PRESENCE improper OF FREE RADICALS, METHOD FOR PROPHYLAXIS OR TREATMENT OF DYSFUNCTION VASCULAR BRAIN AND DISORDERS CAUSED BY THE IMPROPER PRESENCE OF FREE RADICALS USING THIS PRODUCT AND USE OF THIS PRODUCT TO PRODUCE A PHARMACEUTICAL COMPOSITION FOR THE PROPHILAXY OR TREATMENT OF PRESSURE DIFFERENTIATED VASCULAR DIFFUNCTIONS The invention relates to the use of a plant extract product comprising the species Trichilia sp, Paullinia cupana (Sapindaceae), Ptychopetalum olacoides (Olacaceae) and Zingiber officinale Zingiberaceae), characterized in that it is an antioxidant and / or vasodilating agent. brain <D>. One product particularly within the scope of the invention is Catuama extract commercially available as Catuama <32>.

BR0102185-0A 2001-05-30 2001-05-30 Use of product comprising catuama extract as an antioxidant or cerebral vasodilating agent, pharmaceutical composition comprising such product for the prophylaxis or treatment of vascular disorders and disorders caused by the improper presence of free radicals, method for the prophylaxis or treatment of cerebral vascular disorders and disorders caused by improper pressing of free radicals using said product and use of said product for the production of a pharmaceutical composition, for the prophylaxis or treatment of vascular disorders and disorders caused by the improper presence of free radicals BR0102185A (en)

Priority Applications (2)

Application Number Priority Date Filing Date Title
BR0102185-0A BR0102185A (en) 2001-05-30 2001-05-30 Use of product comprising catuama extract as an antioxidant or cerebral vasodilating agent, pharmaceutical composition comprising such product for the prophylaxis or treatment of vascular disorders and disorders caused by the improper presence of free radicals, method for the prophylaxis or treatment of cerebral vascular disorders and disorders caused by improper pressing of free radicals using said product and use of said product for the production of a pharmaceutical composition, for the prophylaxis or treatment of vascular disorders and disorders caused by the improper presence of free radicals
PCT/BR2001/000091 WO2002096441A1 (en) 2001-05-30 2001-07-31 Use of a product comprising catuama extract as an antioxidant and cerebral vasodilator agent

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
BR0102185-0A BR0102185A (en) 2001-05-30 2001-05-30 Use of product comprising catuama extract as an antioxidant or cerebral vasodilating agent, pharmaceutical composition comprising such product for the prophylaxis or treatment of vascular disorders and disorders caused by the improper presence of free radicals, method for the prophylaxis or treatment of cerebral vascular disorders and disorders caused by improper pressing of free radicals using said product and use of said product for the production of a pharmaceutical composition, for the prophylaxis or treatment of vascular disorders and disorders caused by the improper presence of free radicals

Publications (1)

Publication Number Publication Date
BR0102185A true BR0102185A (en) 2003-02-18

Family

ID=3947380

Family Applications (1)

Application Number Title Priority Date Filing Date
BR0102185-0A BR0102185A (en) 2001-05-30 2001-05-30 Use of product comprising catuama extract as an antioxidant or cerebral vasodilating agent, pharmaceutical composition comprising such product for the prophylaxis or treatment of vascular disorders and disorders caused by the improper presence of free radicals, method for the prophylaxis or treatment of cerebral vascular disorders and disorders caused by improper pressing of free radicals using said product and use of said product for the production of a pharmaceutical composition, for the prophylaxis or treatment of vascular disorders and disorders caused by the improper presence of free radicals

Country Status (2)

Country Link
BR (1) BR0102185A (en)
WO (1) WO2002096441A1 (en)

Families Citing this family (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
BR0302750A (en) 2003-08-08 2005-03-29 Catarinense S A Lab Product use comprising plant material of the species trichilia sp. associated or not for the reversal / combat of ventricular fibrillation; pharmaceutical composition comprising said plant material for reversing / combating ventricular fibrillation; method for reversing / combating ventricular fibrillation using said plant material; use of said plant material for the production of a pharmaceutical composition for reversing / combating ventricular fibrillation

Family Cites Families (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
BR9703946A (en) * 1997-07-10 1999-03-09 Catarinense S A Lab Use of selected plant material of the trichilia species for the preparation of pharmaceutical formulations and pharmaceutical compositions containing said plant material

Also Published As

Publication number Publication date
WO2002096441A1 (en) 2002-12-05

Similar Documents

Publication Publication Date Title
SG146648A1 (en) Pharmaceutical compositions for treating premature ejaculation by pulmonary inhalation
DK2263480T3 (en) Composition for promoting bone growth and maintaining bone health, including Mentha extracts
GEP20053510B (en) Substituted Pyrrolopyridinone Derivatives Useful as Phosphodiesterase Inhibitors
LT2004060A (en) A composition for treating neurocerebrovascular disorders
ATE492279T1 (en) BUPROPINE METABOLITES FOR THE TREATMENT OF DEMENTIA AND OTHER CEREBROVACCULAR DISEASES
WO2003028692A3 (en) Acne treatment using oleanolic acid
BG108461A (en) Agent containing fat (oil), which contains oniion extract, the production and use thereof for caring, preventing or treating damaged skin tissue, especially scarred tissue
ECSP055706A (en) COMPOSITION THAT INCLUDES PANAX GINSENG AND PAULLINIA CUPANA EXTRACTS
ATE556706T1 (en) FAT ALCOHOL-DRUG CONJUGATES
AU8830801A (en) Use of derivatives of valproic acid amides and 2-valproenic acid amides for the treatment or prevention of pain and/or headache disorders
MXPA06000660A (en) Use of a cosmetic or pharmaceutical composition, comprising a lupeol-rich extract as an active ingredient for stimulating the synthesis of heat shock proteins.
ATE318610T1 (en) ORAL COMPOSITIONS FOR TREATING SCALP DISEASES
HUP0300732A2 (en) Plant-derived and synthetic phenolic compounds and plant extracts, effective in the treatment and prevention of chlamydial infections
BR0210650A (en) Tablet, and use of it
NO20013787L (en) Soybean extract containing lipids, process for its preparation and pharmaceutical and cosmetic compositions
ATE182789T1 (en) MEDICINAL COMPOSITION FOR THE PROPHYLAXIS AND TREATMENT OF PREMATURE Ejaculation
AR008506A1 (en) PHARMACEUTICAL COMPOSITION.
BR0102185A (en) Use of product comprising catuama extract as an antioxidant or cerebral vasodilating agent, pharmaceutical composition comprising such product for the prophylaxis or treatment of vascular disorders and disorders caused by the improper presence of free radicals, method for the prophylaxis or treatment of cerebral vascular disorders and disorders caused by improper pressing of free radicals using said product and use of said product for the production of a pharmaceutical composition, for the prophylaxis or treatment of vascular disorders and disorders caused by the improper presence of free radicals
MY134867A (en) Bioactive fraction of eurycoma longifolia
ATE215376T1 (en) OINTMENT FOR THE TREATMENT OF BURNS AND OTHER SKIN DISEASES
BR0102186A (en) Use of product comprising catuama extract as antithromboembolic agent, pharmaceutical composition comprising such product for treatment or prevention of thromboembolic disorders, method for treating thromboembolic disorders using said product and use of said product for producing a pharmaceutical composition for treating or preventing thromboembolic disorders
ATE548048T1 (en) ONCOMODULIN FOR THE TREATMENT OF NEUROLOGICAL DISEASES
BR0102184A (en) Use of product comprising catuama extract as an antidepressant agent and in anxiety disorders, pharmaceutical composition comprising such product for treating or preventing depression and / or anxiety disorders, method for treating or preventing depression and / or anxiety disorders using said product and use of said product for producing a pharmaceutical composition for treating or preventing depression and / or anxiety disorders
BR0214959A (en) Pharmaceutical composition for the prevention and treatment of premature ejaculation and / or sexual stimulation hypersensitivity
BRPI0102184B8 (en) use of a catuama extract product

Legal Events

Date Code Title Description
B06F Objections, documents and/or translations needed after an examination request according art. 34 industrial property law
B07D Technical examination (opinion) related to article 229 of industrial property law
B07E Notice of approval relating to section 229 industrial property law

Free format text: NOTIFICACAO DE ANUENCIA RELACIONADA COM O ART 229 DA LPI

B15K Others concerning applications: alteration of classification

Free format text: ALTERADO DA INT. CL.: A61K 35/78, A61P 9/08.

Ipc: A61K 36/185 (2006.01), A61K 36/58 (2006.01), A61K

B07A Technical examination (opinion): publication of technical examination (opinion)
B09B Decision: refusal

Free format text: INDEFIRO O PEDIDO DE ACORDO COM O ART .8O COMBINADO COM ART. 13 DA LPI.

B09B Decision: refusal

Free format text: MANTIDO O INDEFERIMENTO UMA VEZ QUE NAO FOI APRESENTADO RECURSO DENTRO DO PRAZO LEGAL.